ERELZI

Google image searchProduct monograph

Active ingredient

etanercept, 50 MG/ML

DIN: 02462850

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: SENSOREADY PEN. SINGLE USE.

Schedule: Prescription / Schedule D

Company: SANDOZ CANADA INCORPORATED

Date: 04-AUG-2017

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AB — Tumor necrosis factor alpha (TNF-alpha) inhibitors (ATC, ATC/DDD)
• L04AB01 — ETANERCEPT (ATC/DDD)

Reference brand drug: Enbrel

External Links for Erelzi

Search on Google

• Erelzi side effects
• Erelzi dosage
• etanercept side effects
• etanercept dosage

Sandoz Canada Incorporated

Go to Sandoz website to see drug product details. Sometimes you can find erelzi photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.